tirzepatide week 2 Update: ⚠️ OKAY FAMILY 💕 on GLP-1 with @freya.meds and here's what I have had so far! So far I have NO FOOD NOISE! It's honestly weird tbh ! Not everything you hear about

miR-323-3p induces cumulus cell apoptosis through IGF1 targeting

Tirzepatide, by contrast, activates both GLP-1 and GIP receptorsa dual mechanism that some research suggests produces 20% greater weight loss in head-to-head trials

Micro-Dosing vs Standard Protocols Understanding the differences between micro-dosing and standard protocols helps determine which approach suits specific situations

Another goal of the study was weight loss, and the drug succeeded there, too: Participants on semaglutide lost about 13% of their body weight, compared with 2.6% for those on placebo, over the course of the year-long trial